As of June 8, 2025, Genedrive PLC (GDR.L) reports a EV/EBITDA of -1.51.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Genedrive PLC's EV/EBITDA to Peers
To better understand Genedrive PLC's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Genedrive PLC (GDR.L) | -1.51 |
| Reflect Scientific Inc (RSCF) | 138.51 |
| Pangaea Oncology SA (PANG.MC) | 73.35 |
| International Isotopes Inc (INIS) | 46.63 |
| Lonza Group AG (LONN.SW) | 40.00 |
| Chemometec A/S (CHEMM.CO) | 38.88 |
Compared to its competitors, Genedrive PLC's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.